HER2 Low Breast Cancer: A New Subtype or a Trojan for Cytotoxic Drug Delivery?

Despite the great progress made in the understanding of the biological behavior of certain types of invasive breast cancer, there is still no single histological or molecular classification that encompasses such diversity and accurately predicts the clinical course of distinct breast cancer subtypes...

Descripción completa

Detalles Bibliográficos
Autores principales: Popović, Marina, Silovski, Tajana, Križić, Marija, Dedić Plavetić, Natalija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179462/
https://www.ncbi.nlm.nih.gov/pubmed/37175916
http://dx.doi.org/10.3390/ijms24098206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179462/
https://www.ncbi.nlm.nih.gov/pubmed/37175916
http://dx.doi.org/10.3390/ijms24098206

Ejemplares similares